 Regional intravenous ketanserin guanethidine therapy Raynaud phenomenon authors results study patients Raynaud phenomenon primary posttraumatic secondary connective tissue diseases regional intravenous injections guanethidine ketanserin drugs different etiopathologic profiles conditions patients substantial clinical improvement remission trophic lesions Conditions secondary tissue disorders much improvement instrumental data intrinsic limitations techniques peripheral blood flow specific type pharmaceutical treatment suitable disease combination therapeutic efficacy substantial reduction total dosage patient